• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Neurocrine Bio Announces Crenessity Availability for CAH Patients

    PR NEWSWIRE

    US FDA approves Neurocrine Biosciences` genetic disorder drug

    REUTERS

    FDA Roundup: December 13, 2024

    PR NEWSWIRE

    FDA Grants Priority Review For Neurocrine`s Crinecerfont In CAH

    PR NEWSWIRE

    Neurocrine Receives Breakthrough Therapy Designation from FDA for Crinecerfont

    PR NEWSWIRE

    Neurocrine Biosciences Announces Phase 3 Pediatric Study Results of Crinecerfont

    PR NEWSWIRE

    Neurocrine`s crinecerfont succeeds in congenital adrenal hyperplasia trial

    PR NEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.